Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure

Journal of the American College of Cardiology

Volumn 50, Issue 9, 2007, Pages 859-867

  López, Begoña ^a   González, Arantxa ^a   Beaumont, Javier ^a   Querejeta, Ramón ^b   Larman, Mariano ^c   Díez, Javier ^a,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Division of Hemodynamics   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FUROSEMIDE; PROCOLLAGEN C PROTEINASE; TORASEMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HUMAN; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; WESTERN BLOTTING;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOTTING, WESTERN; ENDOCARDIUM; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; FUROSEMIDE; HEART; HEART FAILURE, CONGESTIVE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIUM; PEPTIDE FRAGMENTS; PILOT PROJECTS; PROCOLLAGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONAMIDES;

EID: 34547933258     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.04.080     Document Type: Article

References (34)

1. Burlew B.S., and Weber K.T. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 18 (2000) 435-442
2. Brower G.L., Gardner J.D., Forman M.F., et al. The relationship between myocardial extracellular matrix remodelling and ventricular function. Eur J Cardiothorac Surg 30 (2006) 604-610
3. Querejeta R., López B., González A., Sánchez E., Larman M., and Díez J. Increased collagen type I synthesis in patients with heart failure of hypertensive origin. Relation to myocardial fibrosis. Circulation 110 (2004) 1263-1268
4. Herpel E., Pritsch M., Koch A., Dengler T.J., Schirmacher P., and Schnabel P.A. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy. Histopathology 48 (2006) 736-747
5. Prockop D.J., and Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Ann Rev Biochem 64 (1995) 403-434
6. Prockop D.J., Sieron A.L., and Li S.W. Procollagen N-proteinase and procollagen C-proteinase. Matrix Biol 16 (1998) 399-408
7. Trackman P.C. Diverse biological functions of extracellular collagen processing enzymes. J Cell Biochem 96 (2005) 927-937
8. Adar R., Kessler E., and Godlberg B. Evidence for a protein that enhances the activity of type I procollagen C-proteinase. Coll Relat Res 6 (1986) 267-277
9. Kessler E., and Adar R. Type I procollagen C-proteinase from mouse fibroblasts: purification and demonstration of a 55 KDa enhancer glycoprotein. Eur J Biochem 186 (1989) 115-121
10. Bode G., Gomis-Ruth F.X., Huber R., Zwilling R., and Stocker W. Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases. Nature 358 (1992) 164-167
11. López B., Querejeta R., González A., Sánchez E., Larman M., and Díez J. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 43 (2004) 2028-2035
12. Ho K.L., Pinsky J.L., Kannel W.B., and Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22 Suppl A (1993) 6A-13A
13. Faris R., Flather M., Purcell H., Henein M., Poole-Wilson P., and Coats A. Current evidence supporting the role of diuretics in heart failure: a meta-analysis of randomised controlled trials. Int J Cardiol 82 (2002) 149-158
14. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. J Am Coll Cardiol 46 (2005) e1-e82
15. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
16. Quinones M.A., Pickering E., and Alexander J.K. Percentage of shortening of the echocardiographic left ventricular dimension: its use in determining ejection fraction and stroke volume. Chest 74 (1978) 59-65
17. Querejeta R., Varo N., López B., et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101 (2000) 1729-1735
18. Díez J., Laviades C., Mayor G., Gil M.J., and Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 91 (1995) 1450-1456
19. López B., González A., Querejeta R., Larman M., and Díez J. Alterations of the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. J Am Coll Cardiol 48 (2006) 89-96
20. Goikoetxea M.J., Beaumont F.J., González A., et al. Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease. Cardiovasc Res 69 (2006) 899-907
21. Muñiz P., Fortuño A., Zalba G., Fortuño M.A., and Díez J. Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth. Nephrol Dial Transplant 16 Suppl 1 (2001) 14-17
22. Hojima Y., van der Rest M., and Prockop D.J. Type I procollagen carboxyl-terminal proteinase from chick embryo tendons. Purification and characterization. J Biol Chem 260 (1985) 15996-16003
23. Lee S., Solow-Cordero D.E., Kessler E., Takahara K., and Greenspan D.S. Transforming growth factor-β regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J Biol Chem 272 (1997) 19059-19066
24. Parsons M., Kessler E., Laurent G.J., Brown R.A., and Bishop J.E. Mechanical load enhances procollagen processing in dermal fibroblasts by regulating levels of procollagen C-proteinase. Exp Cell Res 252 (1999) 319-331
25. Yoshida J., Yamamoto K., Mano T., et al. Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. Cardiovasc Res 68 (2005) 118-127
26. Shalitin N., Schlesinger H., Levy M.J., Kessler E., and Kessler-Icekson G. Expression of procollagen C-proteinase enhancer in cultured rat heart fibroblasts: evidence for co-regulation with type I collagen. J Cell Biochem 90 (2003) 397-407
27. Kessler-Icekson G., Schlesinger H., Freimann S., and Kessler E. Expression of procollagen C-proteinase enhancer-1 in the remodelling rat heart is stimulated by aldosterone. Int J Biochem Cell Biol 38 (2006) 358-365
28. Tsutamoto T., Sakai H., Wada A., et al. Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 44 (2004) 2252-2253
29. Uchida T., Yamanaga K., Nishikawara M., Ohkati Y., Kido H., and Watanabe M. Anti-aldosteronic effect of torasemide. Eur J Pharmacol 205 (1991) 145-150
30. Dankwardt S.M., Mrtin R.L., Chan C.S., et al. Amino acid derived sulphonamide hydroxamates as inhibitors of procollagen C-proteinase: solid-phase synthesis of ornithine analogues. Bioorg Med Chem Lett 11 (2001) 2085-2088
31. Danilowski A., Filic D., Oresic M., and Dumic M. Chemistry of torasemide. Molecular and crystal structure of new polymorph N. Croat Chem Acta 74 (2001) 103-120
32. González A., López B., and Díez J. New directions in the assessment and treatment of hypertensive heart disease. Curr Opin Nephrol Hypertens 14 (2005) 428-434
33. Byers P.H. Disorders of collagen biosynthesis and structure. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Basis of Inherited Disease. 7th edition (1995), McGraw-Hill, New York, NY 4029-4077
34. Miyahara M., Njieha F.K., and Prockop D.J. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases. J Biol Chem 257 (1982) 8442-8448